Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07496515Phase 2Not yet recruiting
Phase 2, randomised, single-blind trial in chalazion (3 arms), sponsored by Jaeb Center for Health Research. Primary endpoints: Improvement or resolution of chalazia at 8 weeks and Proportion of participants with new chalazia at 12 months. Planned start Feb 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07496515.